|
2025
|
G/S
|
Dermatological pharmaceutical preparations; pharmaceutical preparations for the treatment of derm... |
|
|
G/S
|
Skin care preparations, namely, lotions, creams, and foams; moisturizing preparations for the ski... |
|
|
Invention
|
Methods of treatment using topical roflumilast compositions. Methods of treating a patient suffer... |
|
|
Invention
|
Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically ... |
|
|
Invention
|
Topical roflumilast formulation having antifungal properties.
The present invention is directed ... |
|
|
Invention
|
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors.
A method... |
|
|
Invention
|
Topical roflumilast formulation having improved delivery and plasma half- life.
The present inve... |
|
|
Invention
|
Inhibition of crystal growth of roflumilast.
Roflumilast crystals have been shown to increase in... |
|
2024
|
Invention
|
Roflumilast formulations with an improved pharmacokinetic profile.
An improved method is provide... |
|
|
Invention
|
Stable formulations of shr0302.
The disclosure relates to stable topical pharmaceutical composit... |
|
|
Invention
|
Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the... |
|
|
Invention
|
Methods of reducing itch using topical roflumilast compositions.
Methods of treating a skin diso... |
|
|
Invention
|
Topical roflumilast for the treatment of atopic/seborrheic dermatitis. Methods of treating a skin... |
|
|
Invention
|
Dosing regimens using topical roflumilast compositions.
Methods of treating a skin disorder or c... |
|
|
Invention
|
Dosing regimens using topical roflumilast compositions. Methods of treating a skin disorder or co... |
|
|
Invention
|
Laureth-4 containing topical formulations.
The present invention is a method and composition com... |
|
|
Invention
|
Treatment of skin conditions using high krafft temperature anionic surfactants.
The present inve... |
|
|
Invention
|
Compositions and methods for deep dermal drug delivery.
Pharmaceutical compositions for the topi... |
|
|
Invention
|
Roflumilast formulations with an improved pharmacokinetic profile. An improved method is provided... |
|
|
Invention
|
Inhibition of crystal growth of roflumilast. Roflumilast crystals have been shown to increase in ... |
|
|
Invention
|
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors. A method ... |
|
|
Invention
|
Topical roflumilast formulation having improved delivery and plasma half-life. The present invent... |
|
|
G/S
|
Promoting public interest and awareness of autoimmune conditions by means of public advocacy Prov... |
|
2023
|
Invention
|
Roflumilast formulations with an improved pharmacokinetic profile. An improved a method of treati... |
|
|
Invention
|
Method and formulation for improving roflumilast skin penetration lag time.
Decreasing skin pene... |
|
|
Invention
|
Laureth-4 containing topical formulations. The present invention is a method and composition comp... |
|
|
Invention
|
Topical roflumilast formulation having antifungal properties. Tinea incognito. Topically administ... |
|
|
Invention
|
Compositions and methods for deep dermal drug delivery. Pharmaceutical compositions for the topic... |
|
2022
|
Invention
|
Topical aerosol foams. The present invention is directed to an aerosol foam composition comprisin... |
|
|
Invention
|
Topical aerosol foams.
The present invention is directed to an aerosol foam composition comprisi... |
|
|
Invention
|
Stable formulations of shr0302. The disclosure relates to stable topical pharmaceutical compositi... |
|
|
Invention
|
Pharmaceutical compositions of spironolactone for deep dermal drug delivery. Pharmaceutical compo... |
|
|
Invention
|
Topical roflumilast aerosol foams. The present invention is directed to an aerosol foam compositi... |
|
|
Invention
|
Self-preserving topical pharmaceutical compositions comprising diethylene glycol monoethyl ether.... |
|
|
G/S
|
Pharmaceutical creams that facilitate the topical administration of pharmaceuticals for the treat... |
|
2021
|
G/S
|
Pharmaceutical preparations, excluding dermatological pharmaceutical preparations; pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceutical creams that facilitate the topical administra... |
|
|
G/S
|
Dermatological pharmaceutical preparations; pharmaceutical
preparations for the treatment of der... |
|
|
G/S
|
Dermatological pharmaceuticals for the treatment of plaque psoriasis; pharmaceutical preparations... |
|
2018
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the diagnosis and treatment of derm... |
|
|
G/S
|
House mark for a full line of pharmaceutical preparations namely pharmaceuticals for use in derma... |
|
|
G/S
|
House mark for a full line of dermatological pharmaceutical preparations; pharmaceutical preparat... |
